The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Natco Pharma

798.75
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events

Performance

Open
822.85
Prev. Close
798.75
Volume
6,51,092
Total traded value
52.01 Cr
Upper Circuit
878.60
Lower Circuit
718.90

Market Depth

Buy order quantity
Sell order quantity
0.00%
98.53%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Ask Price
Qty
798.75
2,186
0.00
0
0.00
0
0.00
0
0.00
0
Ask Total
2,186

Analyst Estimates

38%
Buy
31%
Hold
38%
Sell
31%
Aggregated by Refinitiv from 13 Analysts

Fundamentals

Market Cap₹14,288Cr
ROE27.20%
P/E Ratio(TTM)7.66
EPS(TTM)104.13
P/B Ratio2.00
Dividend Yield1.19%
Industry P/E34.00
Book Value399.19
Debt to Equity0.03
Face Value2
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
7961,1101,4111,435651Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Natco Pharma

Natco Pharma Limited is an India-based vertically integrated, research and development (R&D)-focused pharmaceutical company. The Company is engaged in the business of pharmaceuticals, which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. The Company deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The Company operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.;
Parent OrganisationNatco Pharma Limited
Managing DirectorShri. V. Nannapaneni
NSE SymbolNATCOPHARM

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Promoters
49.62%
Retail And Others
26.87%
Foreign Institutions
17.94%
Other Domestic Institutions
3.66%
Mutual Funds
1.92%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Laurus Labs
NA
(0.00%)
165.44
Piramal Pharma Ltd.
NA
(0.00%)
774.14
Suven Pharmaceuticals
NA
(0.00%)
105.72
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.46
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.1
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW